Open AccessPB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB VS AN INVESTIGATOR‐SELECTED TKI IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP)
Author(s) -
Hughes T.,
Cortes J.,
Takahashi N.,
Larson R.,
Issa G.,
Bombaci F.,
Ramscar N.,
Kapoor S.,
Ifrah S.,
Hochhaus A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850468.09658.81
Subject(s) - bosutinib , nilotinib , medicine , dasatinib , imatinib , adverse effect , oncology , ponatinib , clinical trial , myeloid leukemia